Page 7 - நொதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நொதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நொதி Today - Breaking & Trending Today

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19


Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19
A recent study, currently available on the
bioRxiv preprint server, indicates that a pair of dual-action monoclonal antibodies derived from an original 2003 SARS survivor could play an important role in the fight against coronavirus disease 2019 (COVID-19) due to their broadly neutralizing activity and the engagement of the immune system via effector function capabilities.
Related Stories
While different vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have already been authorized and used pervasively, the goal of swiftly reaching herd immunity may be hampered by supply issues, vaccine hesitancy, and the spread of viral variants. Likewise, those with underlying immunodeficiency may be at risk despite vaccination. ....

United Kingdom , United States , South Africa , San Francisco , Vir Biotechnology , Humabs Biomed , Corona Virus , Coronavirus Disease Covid 19 , Immune System , In Vitro , In Vivo , Sars Cov 2 , Severe Acute Respiratory , Severe Acute Respiratory Syndrome , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , வீர் உயிரி தொழில்நுட்பவியல் , கொரோனா வைரஸ் , நோய் எதிர்ப்பு சக்தி அமைப்பு , இல் விட்ரோ , இல் விவோ , சர்வதேச பரவல் , கடுமையானது எடுப்போசை சுவாச , கடுமையானது எடுப்போசை சுவாச நோய்க்குறி ,

Which biomarkers can help predict severe COVID-19?


Which biomarkers can help predict severe COVID-19?
The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 119 million confirmed cases and over 2.6 million deaths so far. Even as vaccines are being rolled out in many countries, supply challenges and cold-chain obstacles are likely to slow down the pace of universal immunization, favoring the emergence of novel vaccine-resistant strains.
The ability to detect potentially fatal illness early on in the course of the disease would enable a swift prioritization of these high-risk individuals for treatment. A new preprint on the
medRxiv server presents an array of biomarkers that may help achieve this laudable goal. ....

Liji Thomas , Host Genetics Initiative , Proteome Wide Mendelian , Genetics Initiative , Corona Virus , Coronavirus Disease Covid 19 , Sars Cov 2 , Immune Response , Severe Acute Respiratory , Severe Acute Respiratory Syndrome , தொகுப்பாளர் ஜெநெடிக்ஸ் முயற்சி , ஜெநெடிக்ஸ் முயற்சி , கொரோனா வைரஸ் , நோய் எதிர்ப்பு சக்தி பதில் , உடல் பருமன் , சர்வதேச பரவல் , கடுமையானது எடுப்போசை சுவாச , கடுமையானது எடுப்போசை சுவாச நோய்க்குறி ,

Welcome To IANS Live - LatestNews - 'Punarnava therapy' helps reduce pathological damage of kidneys: Study


Photo Credit: IANS
IANSLive
New Delhi, March 13 (IANS) A latest research by Jamia Hamdard University here suggests that certain ayurvedic formulations can reduce pathologic damage of the kidneys. The study claims that the herbal medicines can help rejuvenate cells of an ailing kidney by cutting down reactive oxygen species (ROS) which is associated with pathological damage of the vital organ.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter. ....

New Delhi , Jamia Hamdard University , News Service , India Private , All Rights , புதியது டெல்ஹி , ஜாமியா ஹம்தர்த் பல்கலைக்கழகம் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Welcome To IANS Live - NATION - 'Punarnava therapy' helps reduce pathological damage of kidneys: Study


Photo Credit: IANS
IANSLive
New Delhi, March 13 (IANS) A latest research by Jamia Hamdard University here suggests that certain ayurvedic formulations can reduce pathologic damage of the kidneys. The study claims that the herbal medicines can help rejuvenate cells of an ailing kidney by cutting down reactive oxygen species (ROS) which is associated with pathological damage of the vital organ.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter. ....

New Delhi , Jamia Hamdard University , News Service , India Private , All Rights , புதியது டெல்ஹி , ஜாமியா ஹம்தர்த் பல்கலைக்கழகம் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Optimized nano-micelles can induce efficient genome editing in the mouse brain


Optimized nano-micelles can induce efficient genome editing in the mouse brain
Mar 12 2021
The research group of Deputy Principal Research Scientist Dr. Satoshi Uchida (Associate Professor, Kyoto Prefectural University of Medicine) at the Innovation Center of NanoMedicine (Director General: Prof. Kazunori Kataoka, Location: Kawasaki-Japan, Abbreviation: iCONM) reported that optimized nano-micelles can induce efficient genome editing in the mouse brain.
The 2020 Chemistry Nobel Prize-winning technology CRISPR/Cas9 holds great promise for treating various diseases such as congenital disorders and viral infections, by correcting the disease-specific genomic sequences.
This technology attracted increasing attention in the last decade as it allows easy targeting of genomic sequences with high precision and low level of undesired off-target gene editing. However, safe and efficient delivery of the Cas9 DNA cutting enzyme and guide RNA (gRNA), which is a short piece of RN ....

Saed Abbasi , Kazunori Kataoka , Kyoto Prefectural University Of Medicine , Innovation Center , Deputy Principal Research Scientist Dr , Deputy Principal Research Scientist , Satoshi Uchida , Associate Professor , Kyoto Prefectural University , Director General , Nobel Prize Winning , Genome Editing , கியோட்டோ ப்ரிஃபெக்சரல் பல்கலைக்கழகம் ஆஃப் மருந்து , கண்டுபிடிப்பு மையம் , துணை ப்ரிந்ஸிபல் ஆராய்ச்சி விஞ்ஞானி டாக்டர் , துணை ப்ரிந்ஸிபல் ஆராய்ச்சி விஞ்ஞானி , சதோஷி உசிதா , இணை ப்ரொஃபெஸர் , கியோட்டோ ப்ரிஃபெக்சரல் பல்கலைக்கழகம் , இயக்குனர் ஜநரல் , நோபல் ப்ரைஸ் வென்றது , மரபணு திருத்துதல் ,